• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

较高的体重指数可能是甲状腺微小乳头状癌患者甲状腺外侵犯的一个预测指标。

Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.

作者信息

Choi Ji Soo, Kim Eun-Kyung, Moon Hee Jung, Kwak Jin Young

机构信息

Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Korea.

出版信息

Endocrine. 2015 Feb;48(1):264-71. doi: 10.1007/s12020-014-0293-z. Epub 2014 May 25.

DOI:10.1007/s12020-014-0293-z
PMID:24858734
Abstract

Recently, higher body mass index (BMI) has been associated with aggressive pathologic features of papillary thyroid carcinoma. The aim of this study was to clarify the relationship between BMI and aggressive pathologic features of papillary thyroid microcarcinoma (PTMC) and to evaluate whether the BMI can be a prognostic factor of PTMC. This retrospective study included 612 PTMC patients who underwent surgical excision at a referral center between April 2006 and December 2007. Patients were grouped according to BMI (<25 or ≥25 kg/m2). Multivariable logistic regression analysis was performed to determine independent predictors of aggressive pathologic features (advanced stage, extrathyroidal extension, and lymph node metastasis), with adjustment for age, gender, tumor size, multifocality, thyroid stimulating hormone (TSH) level, and BMI (value/group). PTMC patients with a BMI≥25 kg/m2 showed significantly higher prevalences of extrathyroidal extension, advanced pathologic TNM stage, and male gender, compared to those of patients with a BMI<25 kg/m2. Lymph node metastasis and mean TSH level were not significantly different between the two BMI subgroups. In multivariable analysis, the BMI≥25 kg/m2 group was positively associated with the presence of extrathyroidal extension (adjusted odds ratio 1.49, P=0.05). Higher BMI was associated with extrathyroidal extension in PTMC patients. This study suggests that the BMI could be considered as a prognostic factor for predicting the presence of extrathyroidal extension and it may help decide the appropriate surgical extent for PTMC patients.

摘要

最近,较高的体重指数(BMI)已与甲状腺乳头状癌的侵袭性病理特征相关联。本研究的目的是阐明BMI与甲状腺微小乳头状癌(PTMC)侵袭性病理特征之间的关系,并评估BMI是否可作为PTMC的预后因素。这项回顾性研究纳入了2006年4月至2007年12月期间在一家转诊中心接受手术切除的612例PTMC患者。患者根据BMI(<25或≥25 kg/m²)分组。进行多变量逻辑回归分析以确定侵袭性病理特征(晚期、甲状腺外侵犯和淋巴结转移)的独立预测因素,并对年龄、性别、肿瘤大小、多灶性、促甲状腺激素(TSH)水平和BMI(值/组)进行校正。与BMI<25 kg/m²的患者相比,BMI≥25 kg/m²的PTMC患者甲状腺外侵犯、高级别病理TNM分期和男性的患病率显著更高。两个BMI亚组之间的淋巴结转移和平均TSH水平无显著差异。在多变量分析中,BMI≥25 kg/m²组与甲状腺外侵犯的存在呈正相关(校正比值比1.49,P = 0.05)。较高的BMI与PTMC患者的甲状腺外侵犯相关。本研究表明,BMI可被视为预测甲状腺外侵犯存在的预后因素,并且它可能有助于确定PTMC患者合适的手术范围。

相似文献

1
Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.较高的体重指数可能是甲状腺微小乳头状癌患者甲状腺外侵犯的一个预测指标。
Endocrine. 2015 Feb;48(1):264-71. doi: 10.1007/s12020-014-0293-z. Epub 2014 May 25.
2
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估
Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.
3
Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma.甲状腺微小乳头状癌患者侧方淋巴结转移及跳跃转移的预测因素
Front Endocrinol (Lausanne). 2024 Jul 2;15:1392247. doi: 10.3389/fendo.2024.1392247. eCollection 2024.
4
Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌转移性淋巴结的危险因素
Cir Esp (Engl Ed). 2020 Apr;98(4):219-225. doi: 10.1016/j.ciresp.2019.10.003. Epub 2020 Jan 21.
5
Gray-scale ultrasonography combined with elastography imaging for the evaluation of papillary thyroid microcarcinoma: as a prognostic clinicopathology factor.灰阶超声联合弹性成像评估甲状腺微小乳头状癌:作为一种预后临床病理因素
Ultrasound Med Biol. 2014 Aug;40(8):1769-77. doi: 10.1016/j.ultrasmedbio.2014.02.015. Epub 2014 Apr 24.
6
Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.术前超声检查和血清促甲状腺激素对预测甲状腺微小乳头状癌或可疑甲状腺微小乳头状癌甲状腺结节中央淋巴结转移的价值
Tumour Biol. 2016 Jun;37(6):7453-9. doi: 10.1007/s13277-015-4535-3. Epub 2015 Dec 17.
7
Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.甲状腺微小乳头状癌甲状腺外侵犯相关的临床病理、免疫组化因素及复发情况
J Cancer Res Ther. 2014 Jan-Mar;10(1):50-5. doi: 10.4103/0973-1482.131366.
8
Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.甲状腺微小乳头状癌主要不同变体对临床病理特征的影响:1041例研究
Int J Clin Oncol. 2018 Feb;23(1):59-65. doi: 10.1007/s10147-017-1170-6. Epub 2017 Jul 25.
9
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
10
Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.不伴有甲状腺外侵犯的单发微小乳头状甲状腺癌侧颈部淋巴结转移的预测因素。
Asian J Surg. 2019 Apr;42(4):563-570. doi: 10.1016/j.asjsur.2018.07.003. Epub 2018 Aug 3.

引用本文的文献

1
Inflammation as a mediator between neck adipose tissue and tumor aggressiveness in hypopharyngeal and laryngeal squamous cell carcinoma.炎症作为下咽和喉鳞状细胞癌颈部脂肪组织与肿瘤侵袭性之间的介质。
Cancer Imaging. 2025 Jul 29;25(1):95. doi: 10.1186/s40644-025-00913-w.
2
The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor?体重指数(BMI)在分化型甲状腺癌中的作用:一个潜在的预后因素?
Biomedicines. 2024 Aug 29;12(9):1962. doi: 10.3390/biomedicines12091962.
3
Clinical and molecular features of progressive papillary thyroid microcarcinoma.

本文引用的文献

1
Should patients with papillary microcarcinoma undergo radioiodine ablation?甲状腺微小乳头状癌患者应该接受放射性碘消融治疗吗?
Endocrine. 2013 Oct;44(2):278-9. doi: 10.1007/s12020-013-0010-3. Epub 2013 Jul 2.
2
"Is there any association between insulin resistance and thyroid cancer? : A case control study".胰岛素抵抗与甲状腺癌之间是否存在关联?:一项病例对照研究。
Endocrine. 2014 Feb;45(1):55-60. doi: 10.1007/s12020-013-9942-x. Epub 2013 Apr 6.
3
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
进展性甲状腺微小乳头状癌的临床和分子特征。
Int J Surg. 2024 Apr 1;110(4):2313-2322. doi: 10.1097/JS9.0000000000001117.
4
Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.肥胖对低-中危甲状腺乳头状癌侵袭性的潜在影响:来自 MASTER 队列研究的结果。
Endocrine. 2023 Oct;82(1):134-142. doi: 10.1007/s12020-023-03416-5. Epub 2023 Jul 29.
5
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.低危分化型甲状腺癌的当前争议:在过度诊断时代减少过度治疗。
J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. doi: 10.1210/clinem/dgac646.
6
The Relationship Between Body Mass Index and Different Regional Patterns of Lymph Node Involvement in Papillary Thyroid Cancers.体重指数与甲状腺乳头状癌不同区域淋巴结受累模式之间的关系
Front Oncol. 2021 Dec 22;11:767245. doi: 10.3389/fonc.2021.767245. eCollection 2021.
7
Influencing Factors and Cumulative Risk Analysis of Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移的影响因素及累积风险分析
Front Oncol. 2021 Sep 30;11:644645. doi: 10.3389/fonc.2021.644645. eCollection 2021.
8
Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.甲状腺乳头状癌侵袭性临床病理特征与体重指数的关系:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Jun 30;12:692879. doi: 10.3389/fendo.2021.692879. eCollection 2021.
9
Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.体重指数与甲状腺乳头状癌临床病理特征的相关性:系统评价和荟萃分析。
World J Surg. 2021 Sep;45(9):2805-2815. doi: 10.1007/s00268-021-06193-2. Epub 2021 Jun 16.
10
Obesity and Overweight Are Associated with Minimal Extrathyroidal Extension, Multifocality and Bilaterality of Papillary Thyroid Cancer.肥胖和超重与甲状腺乳头状癌的最小甲状腺外扩展、多灶性和双侧性相关。
J Clin Med. 2021 Mar 2;10(5):970. doi: 10.3390/jcm10050970.
甲状腺微小癌术后残留者是否真的不应接受碘-131 消融治疗?
Endocrine. 2013 Oct;44(2):426-33. doi: 10.1007/s12020-013-9935-9. Epub 2013 Mar 28.
4
Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.甲状腺全切除术与甲状腺叶切除术治疗甲状腺微小乳头状癌的长期疗效:倾向评分匹配后对比分析。
Thyroid. 2013 Nov;23(11):1408-15. doi: 10.1089/thy.2012.0463. Epub 2013 Jul 17.
5
Risk of advanced papillary thyroid cancer in obese patients.肥胖患者发生晚期甲状腺乳头状癌的风险。
Arch Surg. 2012 Sep;147(9):805-11. doi: 10.1001/archsurg.2012.713.
6
Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.体重指数与甲状腺乳头状癌临床病理特征的相关性。
Clin Endocrinol (Oxf). 2013 Jan;78(1):134-40. doi: 10.1111/j.1365-2265.2012.04506.x.
7
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.促甲状腺激素与甲状腺癌诊断:系统评价和剂量反应荟萃分析。
J Clin Endocrinol Metab. 2012 Aug;97(8):2682-92. doi: 10.1210/jc.2012-1083. Epub 2012 May 23.
8
Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies.循环脂联素与甲状腺癌风险呈负相关:体内和体外研究。
J Clin Endocrinol Metab. 2011 Dec;96(12):E2023-8. doi: 10.1210/jc.2010-1908. Epub 2011 Sep 21.
9
Staging of papillary thyroid carcinoma with ultrasonography: performance in a large series.超声在甲状腺乳头状癌分期中的表现:一项大系列研究。
Ann Surg Oncol. 2011 Dec;18(13):3572-8. doi: 10.1245/s10434-011-1783-3. Epub 2011 May 19.
10
Incidental papillary microcarcinoma of the thyroid--further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up.甲状腺偶然发现的微小乳头状癌——恶性潜能极低的进一步证据:一项长达 30 年随访的回顾性临床病理研究。
Ann Surg Oncol. 2011 Nov;18(12):3430-6. doi: 10.1245/s10434-011-1663-x. Epub 2011 Mar 23.